Spring Creek Capital’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Spring Creek Capital’s Portfolio IBER.U Stock Details IBER.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-400,000	Closed	-$3.94M	–	633
2021 Q1	$3.94M	Buy	+400,000	New	+$4M	0.17%	101

Other funds holding IBER.U

Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

OPU

Omni Partners US Irvine, California $1.95B AUM

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Spring Creek Capital's IBER.U Position: Q2 2021 in Review

Spring Creek Capital sold out of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) in Q2 2021, closing a stake of 400,000 shares — an estimated $3.94M sold.

Spring Creek Capital first reported a position in IBER.U in Q1 2021 and held it in 1 quarter. The position peaked at $3.94M in Q1 2021. 34 funds tracked by Wall St. Rank hold IBER.U as of Q2 2021.

Spring Creek Capital reported no remaining Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position as of Q2 2021 after selling out during the quarter.
Spring Creek Capital sold 400,000 Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant shares in Q2 2021, an estimated $3.94M.
Spring Creek Capital first reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in Q1 2021 and held it in 1 quarter.
Spring Creek Capital's Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position peaked at $3.94M in Q1 2021.
34 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant as of Q2 2021.

Based on Spring Creek Capital's 13F filing for Q2 2021, filed 13 Aug 2021.